<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:ns2="http://www.sec.gov/edgar/common">
    <headerData>
        <submissionType>144</submissionType>
        <filerInfo>
            <filer>
                <filerCredentials>
                    <cik>0001197018</cik>
                    <ccc>XXXXXXXX</ccc>
                </filerCredentials>
            </filer>
            <liveTestFlag>LIVE</liveTestFlag>



        </filerInfo>
    </headerData>
    <formData>
        <issuerInfo>
            <issuerCik>0001805387</issuerCik>
            <issuerName>CEREVEL THERAPEUTICS HOLDINGS, INC.</issuerName>
            <secFileNumber>001-39311</secFileNumber>
            <issuerAddress>
                <ns2:street1>222 Jacobs Street, Suite 200</ns2:street1>
                <ns2:city>Cambridge</ns2:city>
                <ns2:stateOrCountry>MA</ns2:stateOrCountry>
                <ns2:zipCode>02141</ns2:zipCode>
            </issuerAddress>
            <issuerContactPhone>8443042048</issuerContactPhone>
            <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>NEAVELLE ANTHONY COLES</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
            <relationshipsToIssuer>
                <relationshipToIssuer>Director</relationshipToIssuer>
                <relationshipToIssuer>Officer</relationshipToIssuer>
            </relationshipsToIssuer>
        </issuerInfo>
        <securitiesInformation>
            <securitiesClassTitle>COMMON</securitiesClassTitle>
            <brokerOrMarketmakerDetails>
                <name>Morgan Stanley Smith Barney LLC Executive Financial Services</name>
                <address>
                    <ns2:street1>1 New York Plaza</ns2:street1>
                    <ns2:street2>8th Floor</ns2:street2>
                    <ns2:city>New York</ns2:city>
                    <ns2:stateOrCountry>NY</ns2:stateOrCountry>
                    <ns2:zipCode>10004</ns2:zipCode>
                </address>
            </brokerOrMarketmakerDetails>
            <noOfUnitsSold>25000</noOfUnitsSold>
            <aggregateMarketValue>1022250.00</aggregateMarketValue>
            <noOfUnitsOutstanding>182194722</noOfUnitsOutstanding>
            <approxSaleDate>07/01/2024</approxSaleDate>
            <securitiesExchangeName>NASDAQ</securitiesExchangeName>
        </securitiesInformation>
        <securitiesToBeSold>
            <securitiesClassTitle>Common</securitiesClassTitle>
            <acquiredDate>07/01/2024</acquiredDate>
            <natureOfAcquisitionTransaction>Exercise of Stock Options</natureOfAcquisitionTransaction>
            <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
            <isGiftTransaction>N</isGiftTransaction>
            <amountOfSecuritiesAcquired>25000</amountOfSecuritiesAcquired>
            <paymentDate>07/01/2024</paymentDate>
            <natureOfPayment>Cash</natureOfPayment>
        </securitiesToBeSold>
        <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
        <securitiesSoldInPast3Months>
            <sellerDetails>
                <name>10b5-1 Sales Plan for NEAVELLE ANTHONY COLES</name>
                <address>
                    <ns2:street1>222 Jacobs Street, Suite 200</ns2:street1>
                    <ns2:city>Cambridge</ns2:city>
                    <ns2:stateOrCountry>MA</ns2:stateOrCountry>
                    <ns2:zipCode>02141</ns2:zipCode>
                </address>
            </sellerDetails>
            <securitiesClassTitle>Common</securitiesClassTitle>
            <saleDate>06/03/2024</saleDate>
            <amountOfSecuritiesSold>50000</amountOfSecuritiesSold>
            <grossProceeds>2030520.00</grossProceeds>
        </securitiesSoldInPast3Months>
        <securitiesSoldInPast3Months>
            <sellerDetails>
                <name>10b5-1 Sales Plan for NEAVELLE ANTHONY COLES</name>
                <address>
                    <ns2:street1>222 Jacobs Street, Suite 200</ns2:street1>
                    <ns2:city>Cambridge</ns2:city>
                    <ns2:stateOrCountry>MA</ns2:stateOrCountry>
                    <ns2:zipCode>02141</ns2:zipCode>
                </address>
            </sellerDetails>
            <securitiesClassTitle>Common</securitiesClassTitle>
            <saleDate>05/10/2024</saleDate>
            <amountOfSecuritiesSold>50000</amountOfSecuritiesSold>
            <grossProceeds>2105125.00</grossProceeds>
        </securitiesSoldInPast3Months>
        <noticeSignature>
            <noticeDate>07/01/2024</noticeDate>
            <planAdoptionDates>
                <planAdoptionDate>09/18/2023</planAdoptionDate>
            </planAdoptionDates>
            <signature>/s/ Neavelle Anthony Coles</signature>
        </noticeSignature>
    </formData>
</edgarSubmission>
[{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 4884}]
144
0001197018
XXXXXXXX
LIVE
0001805387
CEREVEL THERAPEUTICS HOLDINGS, INC.
001-39311
222 Jacobs Street, Suite 200
Cambridge
MA
02141
8443042048
NEAVELLE ANTHONY COLES
Director
Officer
COMMON
Morgan Stanley Smith Barney LLC Executive Financial Services
1 New York Plaza
8th Floor
New York
NY
10004
25000
1022250.00
182194722
07/01/2024
NASDAQ
Common
07/01/2024
Exercise of Stock Options
Issuer
N
25000
07/01/2024
Cash
N
10b5-1 Sales Plan for NEAVELLE ANTHONY COLES
222 Jacobs Street, Suite 200
Cambridge
MA
02141
Common
06/03/2024
50000
2030520.00
10b5-1 Sales Plan for NEAVELLE ANTHONY COLES
222 Jacobs Street, Suite 200
Cambridge
MA
02141
Common
05/10/2024
50000
2105125.00
07/01/2024
09/18/2023
/s/ Neavelle Anthony Coles